Shiv K Singh Selected Research

NFATC Transcription Factors

12/2021	Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer.
3/2016	GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.
2/2015	Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity.
8/2011	Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiv K Singh Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 09/2009
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2011
5	Adenocarcinoma 01/2022 - 01/2019
4	Inflammation (Inflammations) 12/2022 - 06/2014
4	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2008
3	Carcinogenesis 06/2014 - 08/2010
2	Infections 07/2019 - 01/2018
1	Fibrosis (Cirrhosis) 12/2022
1	Disease Progression 12/2022
1	Non-alcoholic Fatty Liver Disease 12/2022
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Necrosis 01/2020
1	Malaria 07/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Inflammatory Breast Neoplasms 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Invasive Pulmonary Aspergillosis 07/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2007
1	Osteoporotic Fractures 09/2007

Drug/Important Bio-Agent (IBA)

6	Transcription Factors (Transcription Factor)IBA 12/2022 - 08/2010
4	Pharmaceutical PreparationsIBA 12/2022 - 10/2019
4	NFATC Transcription FactorsIBA 12/2021 - 08/2011
3	CytokinesIBA 01/2018 - 09/2009
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2018 - 07/2009
2	ChromatinIBA 12/2021 - 09/2013
2	CollagenIBA 10/2020 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2019
2	Gemcitabine FDA Link 07/2020 - 10/2019
2	CyclinsIBA 03/2016 - 06/2014
2	Zoledronic Acid (Zometa)FDA Link 08/2011 - 01/2010
1	ursodoxicoltaurineIBA 12/2022
1	EnzymesIBA 12/2022
1	InflammasomesIBA 12/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2021
1	MethyltransferasesIBA 12/2021
1	Hyaluronic Acid (Hyaluronan)IBA 10/2020
1	Antimalarials (Antimalarial Agents)IBA 07/2019
1	Complement Factor H (Factor H)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	PlatinumIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	epidermal growth factor receptor VIIIIBA 01/2019
1	VimentinIBA 01/2018
1	ChemokinesIBA 01/2018
1	EuchromatinIBA 03/2016
1	Glycogen Synthase KinasesIBA 03/2016
1	NucleoproteinsIBA 06/2014
1	HeterochromatinIBA 02/2012
1	ThymidineIBA 02/2012
1	Serine (L-Serine)FDA Link 08/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2010
1	Growth InhibitorsIBA 08/2010
1	Diphosphonates (Bisphosphonates)IBA 01/2010
1	Estrogen ReceptorsIBA 01/2010
1	OsteoprotegerinIBA 09/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2009
1	Therapeutic UsesIBA 07/2009
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2008
1	LigandsIBA 01/2008
1	Anabolic AgentsIBA 09/2007
1	Islet Amyloid PolypeptideIBA 09/2007
1	Insulin (Novolin)FDA Link 09/2007

Therapy/Procedure

3	Therapeutics 10/2020 - 01/2019
1	Precision Medicine 01/2022
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 01/2019
1	Glycemic Control 09/2007